Abstract: The invention relates to a method for the stimulation of the reactions of natural defence of agronomically useful and of decorative plants, characterized by the fact that there is applied on the plants to be treated an aqueous composition comprising an efficient concentration in sulfate of ? 1-3 glucan and more particularly a concentration of at least 1 mg/l, preferably of at least 5 mg/l, and still more preferably of at least 10 mg/l in laminarin sulfate, whose degree of sulfatation is higher than or equal to 1.9, preferably from 2 to 2.5, the said composition being applied to the culture or crop to be treated in an amount sufficient to provide per hectare an efficient amount of sulfate of ? 1-3 glucan, and in the case of laminarin sulfate in an amount sufficient to provide from 0.4 to 4 g of laminarin sulfate per hectare.
Type:
Grant
Filed:
February 20, 2003
Date of Patent:
December 27, 2005
Assignee:
Laboratoires Goemar S.A.
Inventors:
Jean-Claude Yvin, Rozenn Menard, Serge Kauffmann, Bernard Fritig
Abstract: To preserve flowers (6) and provide aromatherapy, low temperature paraffin (1) is heated (2) to a liquid state of approximately 130 degrees Fahrenheit. A floral nutrient and preservative (3) such as a saccharide such as sugar is then added to the low temperature paraffin (1). Optionally, scents (4) and/or color dyes (5) are also added. The heads of flowers (6) to be preserved are then dipped (7) in this paraffin mixture for one to three seconds and thereafter allowed to dry. The flower (6) can then be used immediately, or optionally hung (8) upside down for one to three weeks prior to use to further improved shelf life. The flower (6) can further be sprayed with a floral spray paint (9).
Abstract: The invention relates to novel herbicidal synergistic active compound combinations comprising heteroaryloxy-acetamides and known herbicidally active compounds and/or safeners described in the description and their use for the selective control of weeds in crops of various useful plants.
Type:
Grant
Filed:
May 9, 2001
Date of Patent:
November 22, 2005
Assignee:
Bayer Cropscience AG
Inventors:
Dieter Feucht, Peter Dahmen, Mark Wilhelm Drewes, Rolf Pontzen, Mathias Kremer
Abstract: A flowering regulator comprising a compound represented by the following formula (I): wherein R1 represents a lower alkyl group, a lower alkenyl group, or a phenyl group which may be substituted, R2 represents a lower alkyl group or a phenyl group which may be substituted, and R3 represents a phenyl group which may be substituted (e.g., 4-(4-chlorophenyl)-2-phenyl-3-(1,2,4-triazoyl)butan-2-ol), or a salt thereof.
Abstract: In accordance with the present invention, there are provided methods of modulating the activity of excitatory amino acid receptors using a specifically defined class of heterocyclic compounds. In one embodiment, there are provided methods of modulating metabotropic glutamate receptors. The present invention also discloses methods of treating disease using heterocyclic compounds.
Type:
Grant
Filed:
August 31, 1999
Date of Patent:
October 18, 2005
Assignee:
Merck & Co., Inc.
Inventors:
Nicholas D. P. Cosford, Ian A. McDonald, Stephen D. Hess, Mark A. Varney
Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
Type:
Grant
Filed:
January 22, 2004
Date of Patent:
October 18, 2005
Assignee:
Schering Corporation
Inventors:
Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
Abstract: Spray-dried particles having improved protein stability are produced by spray-drying a mixture including a protein, a phospholipid and an organic-aqueous co-solvent. Spray-dried particles which include at least 1 weight % phospholipid, having a tap density of less than 0.4 g/cm3 can be prepared. The particles can be delivered to the pulmonary system of a patient.
Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
Type:
Grant
Filed:
January 22, 2004
Date of Patent:
September 27, 2005
Assignee:
Schering Corporation
Inventors:
Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
Abstract: Applicants have discovered that cyclic and acyclic ketone acids, such as dehydroacetic acid, and salts thereof as well as an aromatic carboxylic acid and salts thereof enhance the performance of iodine containing biocides as antimicrobial agents and preservatives. The present invention provides a composition comprising (a) an iodine containing biocide; and (b) (i) a ketone acid or salt thereof, (ii) an aromatic carboxylic acid or a salt thereof, or (iii) a mixture thereof. Preferably, the ketone acid is a cyclic ketone acid and the aromatic carboxylic acid is salicylic acid.
Type:
Grant
Filed:
February 28, 2002
Date of Patent:
September 20, 2005
Assignee:
Lonza Inc.
Inventors:
Patrick Jay Lutz, Olga Borokhov, Susan Alcorn Ban
Abstract: The field of colonic diagnostic and surgical procedures is hampered by the lack of optimal means available to cleanse the colon. A compromise between convenient, distasteful, solid or low volume, hyperosmotic solutions which cause considerable fluid and electrolyte imbalances in patients and large volume, difficult to consume, iso-osmotic solutions has had to be made heretofore. This invention describes a low volume, hyper-osmotic solution consisting of sulfate salts with and with out polyethylene glycol. Unlike prior art, this composition is useful for the cleansing of the bowel and, in lower volumes, as a laxative, without producing clinically significant changes in bodily function.
Abstract: There is disclosed a medical device for implantation that acts to prevent transmission of infectious agents. Specifically, the present invention provides implantable devices, such as catheters or living skin matrices or wound dressings, for insertion into various body cavities or over wound sites to confer to the site microbicidal or virucidal activity. Devices in the disclosure designed as vaginal inserts also exhibit contraceptive spermicidal activity. The coated devices or devices having the inventive polymeric material interspersed throughout are formed into appropriate shapes according to their contemplated uses (such as catheters or Foley catheters). Further, the present invention provides devices for providing therapeutic anti-microbial activity into an infected body cavity or on an infected wound site.
Abstract: Microbicidal formulations are described which are preferably ecologically friendly and non-toxic to mammals, and are highly effective against a broad spectrum of detrimental pathogenic microorganisms. The microbicidal formulation contains complexes having the formula R-M, wherein R is at least one organic chelating moiety and M is at least one metal ion which is microbicidal to at least one microorganism. These complexes can disrupt microorganism activities by penetrating the natural protecting bio-films of such microorganisms through the reaction of the R-group with the organic constituents of these microorganisms while releasing M into their intra-cellular media. Thus, this process exhibits its biocidal activities from the inside-out, contrary to other methods which rely on damaging the protective biofilms.
Abstract: Disclosed herein is a oral extended release dosage form comprising a plurality of granules of an effective amount of a pharmaceutically active compound, at least one amino acid, and an intragranular polymer in which the granule is dispersed within a hydrophilic extragranular polymer matrix which is more rapidly hydrating than the intragranular polymer. The amino acid is selected for hydropathy characteristics depending on solubility characteristics of the active compound.
Abstract: There is provided an agrochemical formulation aid composition for preparing bioactive and sprayable agrochemicals, wherein various components for the composition were selected from mineral oil paraffinic distillate and/or aromatic hydrocarbon distillate; 2N-octanol; oleyl-cetyl; alcohol polyoxyethylene (2) oleylether; polyoxyethylene (8) nonylphenolethin and/or ethoxylated tallow amine blend; lauryl sulphate; fatty alcohol alkoxylate; terpenes, diammonium phosphate; tetrasodium ethylene diamine tetracetate; cab-o-sil; fatty acid methyl ester; (C18) free fatty acid blend; N-butanol; and methyl alcohol. Also provided are methods of preparing the formulation aid composition on site by mixing various components and methods of preparing sprayable and bioactive agrochemical systems using the formulation aid and non-formulated or formulated agrochemicals. Also provided are uses of the formulation aid in preparing sprayable and bioactive agrochemical systems for controlling pests.
Type:
Grant
Filed:
October 26, 2001
Date of Patent:
August 30, 2005
Assignee:
Adjuvants Plus Inc.
Inventors:
James F. Stewart, Heinrich J. Reinartz, William G. Brown
Abstract: A method for treating a seedling by dipping the roots of the seedling into a composition containing a slow release, particulate urea-formaldehyde polymer, which is useful as a fertilizer for enhancing the extended delivery of nitrogen needed for plant development and growth and to the composition useful as the root dip, or as a soil drench.
Type:
Grant
Filed:
March 26, 2003
Date of Patent:
August 30, 2005
Assignee:
Georgia-Pacific Resins, Inc.
Inventors:
Stacey L. Wertz, Kurt Gabrielson, Robbie Kelly, Paul Baxter, James Knight, James Wright, Charles R. Davis
Abstract: Aerosol formulations suitable for use in pressurised metered dose inhalers comprise a hydrofluoroalkane propellant, an medicament for inhalation and a surfactant which is a a C8–C16 fatty acid or salt thereof, a bile salt, a phospholipid, or an alkyl saccharide.
Type:
Grant
Filed:
December 19, 1995
Date of Patent:
August 23, 2005
Assignee:
AstraZeneca AB
Inventors:
Kjell Bäckström, Magnus Dahlbäck, Ann Johansson, Göran Källstrand, Elisabet Lindqvist
Abstract: A method for preparing a calcium phosphate pasty material for injection which after, setting, is designed to form an apatite material consists in: producing from water and calcium phosphates pasty mixture capable of developing, hardening and forming a hydroxyapatite. The method is characterised in that it consists in adding to the calcic phosphates or to the pasty mixture before it is injected a methicone having relative to the mixture more than 0.30 wt. % and less than 10 wt. %. The resulting material can be injected, that is it can be transported in pasty form into a conduit under moderate pressure levels. The material sets on the site of implantation and hardens to form an apatite biomaterial in a manner similar to known methicone-free calcium phosphate mixtures.
Abstract: The present invention relates to a synergistic herbicidal composition comprising; (A) mesotrione, and: (B) a second herbicide selected from; (B1) triazines (B2) triazolinones (B3) triazinones (B4) imidazolinones (B5) dicamba (B6) flumetsulam (B7) trifloxysulfuron (B8) tritosulfuron (B9) triasulfuron (B10) pyriftalid (B11) prosulfocarb (B12) pretilachlor (B13) cinosulfuron, or their herbicidally effective salts. A method of controlling the growth of undesirable vegetation, particularly in crops, using this synergistic composition is also disclosed.
Abstract: Uniform portions of fine powders are deposited on a substrate by electrostatic attraction in which the charge of the electric field and polarity of the charged particles are varied repeatedly to form a buildup of powder on the carrier surface.
Type:
Grant
Filed:
April 27, 1999
Date of Patent:
August 2, 2005
Assignee:
Microdose Technologies, Inc.
Inventors:
Richard Fotland, John Bowers, William Jameson
Abstract: Use of at least one aminophenol derivative of formula (I) below: in which: R represents a hydrogen atom or a radical —COR2, wherein R2 represents a saturated or unsaturated, linear, cyclic or branched, optionally hydroxylated, C1 to C30 hydrocarbon or alkoxy radical; R1 is a radical of formula (a), (b) or (c) below: (a) —CO—NR3R4 (b) —CO—O—R5 (c) —SO2—R5 wherein R3 represents a hydrogen atom or a linear or branched, saturated or unsaturated, optionally hydroxylated, C1 to C4 hydrocarbon radical, R4 represents a hydrogen atom or a saturated or unsaturated, linear, cyclic or branched, optionally hydroxylated, C1 to C30 hydrocarbon radical, and R5 represents a saturated or unsaturated, linear, cyclic or branched, optionally hydroxylated, C1 to C30 hydrocarbon radical, in a depigmenting and/or bleaching cosmetic composition for human skin, body hairs or head hair; compositions comprising the derivatives of formula (I) and a process for depigmenting and/or bleaching the skin, body hairs and/or head hairs.
Type:
Grant
Filed:
April 19, 2002
Date of Patent:
August 2, 2005
Assignee:
L'Oreal
Inventors:
Michel Philippe, Remy Tuloup, Christian Blaise